IMMUNOVANT, INC. Shares Issued
IMMUNOVANT, INC. (IMVT) had Shares Issued of 206.26 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-06
- 2026-06-30: Common Stock, Shares, Issued 206.26M shares.
- 2026-03-31: Common Stock, Shares, Issued 203.94M shares.
- 2025-12-31: Common Stock, Shares, Issued 203.32M shares.
- 2025-09-30: Common Stock, Shares, Issued 174.53M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 206.26M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 203.94M shares 10-Q · filed 2026-08-06 | |
| 2025-12-31 | 203.32M shares 10-Q · filed 2026-02-06 | |
| 2025-09-30 | 174.53M shares 10-Q · filed 2025-11-10 | |
| 2025-06-30 | 171.07M shares 10-Q · filed 2025-08-11 | |
| 2025-03-31 | 170.11M shares 10-K · filed 2026-05-20 | |
| 2024-12-31 | 147.20M shares 10-Q · filed 2025-02-06 | |
| 2024-09-30 | 146.57M shares 10-Q · filed 2024-11-07 | |
| 2024-06-30 | 146.20M shares 10-Q · filed 2024-08-06 | |
| 2024-03-31 | 145.58M shares 10-K · filed 2025-05-29 | |
| 2023-12-31 | 145.09M shares 10-Q · filed 2024-02-12 | |
| 2023-09-30 | 131.44M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 130.57M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 130.33M shares 10-K · filed 2024-05-29 | |
| 2022-12-31 | 129.26M shares 10-Q · filed 2023-02-03 | |
| 2022-09-30 | 116.61M shares 10-Q · filed 2022-11-04 | |
| 2022-06-30 | 116.52M shares 10-Q · filed 2022-08-05 | |
| 2022-03-31 | 116.48M shares 10-K · filed 2023-05-22 | |
| 2021-12-31 | 115.11M shares 10-Q · filed 2022-02-04 | |
| 2021-09-30 | 115.00M shares 10-Q · filed 2021-11-05 | |
| 2021-06-30 | 97.98M shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | 97.97M shares 10-K · filed 2022-06-08 | |
| 2020-12-31 | 97.97M shares 10-Q · filed 2021-02-16 | |
| 2020-09-30 | 97.89M shares 10-Q · filed 2020-11-12 | |
| 2020-06-30 | 81.81M shares 10-Q · filed 2020-08-12 | |
| 2020-03-31 | 56.46M shares 10-K · filed 2021-06-01 | |
| 2019-12-31 | 56.46M shares 10-Q · filed 2020-02-14 | |
| 2019-09-30 | 3.53M shares 10-Q · filed 2019-11-13 | |
| 2019-06-30 | 3.55M shares 10-Q · filed 2019-08-12 | |
| 2019-03-31 | 38.59M shares 10-K · filed 2020-06-29 | 2.88M shares 10-Q · filed 2019-06-12 |
| 2018-12-31 | 2.88M shares 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |